BamSEC and AlphaSense Join Forces
Learn More

Maze Therapeutics Inc. – Transcripts

NASDAQ: MAZE    
Share price (9/30/26): $27.18    
Market cap (9/30/26): $1.510 billion
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Other Revised 09/10/26 Maze Therapeutics, Inc. Presents at Citigroup’s Biopharma Back to School Summit 2026, Sep-10-2026 02:20 PM 09/10/26
Other Revised 06/10/26 Maze Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-10-2026 08:40 AM 06/10/26
CY 2025
Other Revised 11/25/25 Maze Therapeutics, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-20-2025 12:00 PM 11/20/25
Other Revised 11/25/25 Maze Therapeutics, Inc. Presents at TD Cowen Immunology and Inflammation Summit, Nov-13-2025 02:00 PM 11/13/25
Other Revised 11/25/25 Maze Therapeutics, Inc. Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference, Nov-11-2025 09:30 AM 11/11/25
Other Revised 09/11/25 Maze Therapeutics, Inc. - Special Call 09/11/25